The connection between auditory or vestibular disorders and neuroinflammatory or neurodegenerative diseases has gained ...

Christina Applegate has made a candid admission about living with Multiple Sclerosis (MS), saying she now has trouble dealing ...

INDIGO is the largest clinical trial conducted in patients living with IgG4-RD--Topline INDIGO results expected by the end of 2025-WALTHAM, ...

Initiated the Phase 2 MoonStone trial, a Phase 2, multicenter, randomized, double-blind, placebo-controlled trial, to evaluate the efficacy and safety of obexelimab in patients with Relapsing Multiple ...

But those kinds of risk factors aren’t enough on their own. People have to be exposed to one or more “triggers” that tip the ...

MS is an inflammatory autoimmune disease marked by extensive damage to the insulating myelin sheath that protects nerves ...

“CSFR is increased in lesions in MS and EAE [experimental autoimmune encephalomyelitis].” Fexagratinib, which was previously ...

According to the National Multiple Sclerosis Society, numbness is one of the most common symptoms of the disease. Another person who was diagnosed with MS said their thighs would feel like they were ...

MS is an inflammatory autoimmune disease marked by extensive damage to the insulating myelin sheath that protects nerves throughout the body. Current treatments focus on controlling the immune ...

Immunic, Inc. ( (IMUX) ) has released its Q3 earnings. Here is a breakdown of the information Immunic, Inc. presented to its investors.

A "groundbreaking" drug is being trialled in the first Brits to cure autoimmune conditions such as lupus and multiple ...